Company profile
Molecular Oncology Almanac
A paired clinical interpretation algorithm and knowledge base for precision cancer medicine.
- Industry
- Biotechnology Research
- Employees
- 2
Molecular Oncology Almanac company summary
Molecular Oncology Almanac is a company in the Biotechnology Research industry. On LinkedIn the company has around 2 employees. Its listed specialties include Precision oncology.
What technology does Molecular Oncology Almanac use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Molecular Oncology Almanac
The Molecular Oncology Almanac (MOAlmanac) is a clinical and biological interpretation algorithm and paired knowledge base for precision oncology. The primary objective of MOAlmanac is to identify and associate molecular alterations with therapeutic sensitivity and resistance as well as disease prognosis. This is done for “first-order” genomic alterations -- individual events such as somatic variants, copy number alterations, fusions, and germline -- as well as “second-order” events -- those that are not associated with one single mutation, and may be descriptive of global processes in the tumor such as tumor mutational burden, microsatellite instability, mutational signatures, and whole-genome doubling. The underlying database of this method is dependent on expert curation of the current body of knowledge on how molecular alterations affect clinical actionability. As the field of precision oncology grows, the quantity of research on how specific alterations affect therapeutic response and patient prognosis expands at an increasing rate. Curating the latest literature and presenting it in an accessible manner increases the abilities of clinicians and researchers alike to rapidly assess the importance of a molecular feature.
Specialties
Compare companies similar to Molecular Oncology Almanac
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Molecular Oncology Almanac moalmanac.org | Biotechnology Research | 2 | - | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Molecular Oncology Almanac
What does Molecular Oncology Almanac do?
The Molecular Oncology Almanac (MOAlmanac) is a clinical and biological interpretation algorithm and paired knowledge base for precision oncology. The primary objective of MOAlmanac is to identify and associate molecular alterations with therapeutic sensitivity and resistance as well as disease prognosis. This is done for “first-order” genomic alterations -- individual events such as somatic variants, copy number alterations, fusions, and germline -- as well as “second-order” events -- those that are not associated with one single mutation, and may be descriptive of global processes in the tumor such as tumor mutational burden, microsatellite instability, mutational signatures, and whole-genome doubling. The underlying database of this method is dependent on expert curation of the current body of knowledge on how molecular alterations affect clinical actionability. As the field of precision oncology grows, the quantity of research on how specific alterations affect therapeutic response and patient prognosis expands at an increasing rate. Curating the latest literature and presenting it in an accessible manner increases the abilities of clinicians and researchers alike to rapidly assess the importance of a molecular feature.
How many employees does Molecular Oncology Almanac have?
Molecular Oncology Almanac has around 2 employees on LinkedIn.
Build a lead list from companies like Molecular Oncology Almanac
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.